Liming Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liming Peng has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Hui Chen
Department of Hematology and Oncology, Changsha First Hospital, Changsha 410005, China
1 shared publication - Jiheng Liu
Department of Hematology and Oncology, Changsha First Hospital, Changsha 410005, China
1 shared publication - Karol Mateusz Pencina
Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre , 1001 Decarie Blvd, Montreal, Quebec H4A 3J1
1 shared publication - Ravi Jasuja
Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 , USA
1 shared publication - Shalender Bhasin
Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115
1 shared publication - Yan-Ling Zheng
Department of Hematology and Oncology, Changsha First Hospital, Changsha 410005, China
1 shared publication
Latest Publications
- 22 February 2022
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 51 (1) , 63-75
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels
- 22 February 2022
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 51 (1) , 63-75
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels
- Open Access
- 28 August 2021
- Published by Hindawi Limited in Scientific Programming
- Vol. 2021, 1-7
Artificial Intelligence-Based Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Evaluation of the Efficacy of Targeted Therapy for Liver Metastasis from Colon Cancer and Nursing
The purpose of this study was to quantitatively evaluate the targeted treatment and nursing effect of patients with liver metastasis of colon cancer by enhanced magnetic resonance imaging. First, Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) images were restored. 35 patients with liver metastases from colon cancer were selected as research subjects and treated by bevacizumab, and high-quality nursing methods were used to improve the psychophysiology of the patients. Enhanced CT examination and DCE-MRI scan were performed before and after the treatment. After the image was processed by the artificial intelligence algorithm, apparent diffusion coefficient (ADC), measurement transmission constant (Ktrans), reflux constant (Kep), extravascular extracellular volume fraction (Ve), and other data on the image were recorded. Two months after the treatment, 35 patients were divided into effective and ineffective groups. It was found that, after treatment, the Kep value and Ktrans value of the effective group were significantly reduced, showing statistically significant differences, and the value was less than 0.05, and the Kep value and Ktrans value of the ineffective group showed no significant changes. The Ve value of the two groups gradually decreased with the progress of the treatment. In the effective group, the Ve values before the treatment, on the third day after the treatment, and on the seventh day after treatment were (0.235 0.134), (0.338 0.116), and (0.457 0.097), respectively. Compared with the Ve values of the ineffective group, there was a statistical difference, F = 3.592, ; the ADC value was negatively correlated with the Ktrans and Kep values, and the results were statistically significant. It was concluded that the above indicators are effective in evaluating the efficacy of the targeted therapy of liver metastasis from colon cancer, and DCE-MRI is of great significance in predicting the efficacy of targeted therapy of liver metastasis from colon cancer.
- 28 August 2021
- Published by Hindawi Limited in Scientific Programming
- Vol. 2021, 1-7
Open AccessArtificial Intelligence-Based Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Evaluation of the Efficacy of Targeted Therapy for Liver Metastasis from Colon Cancer and Nursing
The purpose of this study was to quantitatively evaluate the targeted treatment and nursing effect of patients with liver metastasis of colon cancer by enhanced magnetic resonance imaging. First, Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) images were restored. 35 patients with liver metastases from colon cancer were selected as research subjects and treated by bevacizumab, and high-quality nursing methods were used to improve the psychophysiology of the patients. Enhanced CT examination and DCE-MRI scan were performed before and after the treatment. After the image was processed by the artificial intelligence algorithm, apparent diffusion coefficient (ADC), measurement transmission constant (Ktrans), reflux constant (Kep), extravascular extracellular volume fraction (Ve), and other data on the image were recorded. Two months after the treatment, 35 patients were divided into effective and ineffective groups. It was found that, after treatment, the Kep value and Ktrans value of the effective group were significantly reduced, showing statistically significant differences, and the value was less than 0.05, and the Kep value and Ktrans value of the ineffective group showed no significant changes. The Ve value of the two groups gradually decreased with the progress of the treatment. In the effective group, the Ve values before the treatment, on the third day after the treatment, and on the seventh day after treatment were (0.235 0.134), (0.338 0.116), and (0.457 0.097), respectively. Compared with the Ve values of the ineffective group, there was a statistical difference, F = 3.592, ; the ADC value was negatively correlated with the Ktrans and Kep values, and the results were statistically significant. It was concluded that the above indicators are effective in evaluating the efficacy of the targeted therapy of liver metastasis from colon cancer, and DCE-MRI is of great significance in predicting the efficacy of targeted therapy of liver metastasis from colon cancer.